- Home
- LEU vs BHC Comparison
LEU vs BHC Comparison
Compare LEU & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEU
- BHC
- Stock Information
- Founded
- LEU 1998
- BHC N/A
- Country
- LEU United States
- BHC Canada
- Employees
- LEU N/A
- BHC N/A
- Industry
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- LEU Industrials
- BHC Health Care
- Exchange
- LEU Nasdaq
- BHC Nasdaq
- Market Cap
- LEU 1.6B
- BHC 1.7B
- IPO Year
- LEU 1998
- BHC N/A
- Fundamental
- Price
- LEU $126.92
- BHC $4.53
- Analyst Decision
- LEU Buy
- BHC Hold
- Analyst Count
- LEU 6
- BHC 5
- Target Price
- LEU $143.40
- BHC $7.20
- AVG Volume (30 Days)
- LEU 1.2M
- BHC 1.5M
- Earning Date
- LEU 05-07-2025
- BHC 04-30-2025
- Dividend Yield
- LEU N/A
- BHC N/A
- EPS Growth
- LEU 40.85
- BHC N/A
- EPS
- LEU 6.39
- BHC N/A
- Revenue
- LEU $471,400,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- LEU $3.22
- BHC $3.71
- Revenue Next Year
- LEU $9.91
- BHC $5.03
- P/E Ratio
- LEU $19.85
- BHC N/A
- Revenue Growth
- LEU 58.72
- BHC 8.53
- 52 Week Low
- LEU $33.51
- BHC $3.96
- 52 Week High
- LEU $136.00
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- LEU 79.42
- BHC 39.91
- Support Level
- LEU $90.83
- BHC $4.50
- Resistance Level
- LEU $136.00
- BHC $4.61
- Average True Range (ATR)
- LEU 7.67
- BHC 0.13
- MACD
- LEU 3.31
- BHC 0.03
- Stochastic Oscillator
- LEU 80.15
- BHC 21.30
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.